Carolyn Blasdel, RN, FNP-BC, OCN
|
''Carolyn Blasdel began caring for patients with CML at the start of the Phase I Gleevec trial in 1998 at Oregon Health & Science University (OHSU) in Portland, Oregon, USA as a clinical research nurse with Dr. Brian Druker, MD. Her current practice focuses on side effect management, patient education, and promoting a high quality of life with excellent treatment outcomes for people living with CML.
She earned a Post-Master’s Certificate from Washington State University, Vancouver, Washington, her Master of Arts degree in Psychosocial Nursing at the University of Washington in Seattle, and her Bachelor of Science in Nursing at the University of Maryland in Baltimore. She is an Oncology Certified Nurse and is also board certified as a Family Nurse Practitioner by the American Nurses Credentialing Center.'' Extract of http://www.cmlsociety.org/?q=node/161 |
 |
More information about Knight Cancer Institute and leukemia,
Oregon Health & Science University (OHSU)
See Dr. Brian Druker and Dr. Michael Mauro and Rob Shick (patient)
Oregon Health & Science University (OHSU)
See Dr. Brian Druker and Dr. Michael Mauro and Rob Shick (patient)
